Stay updated on Nivolumab Ibrutinib in CLL Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ibrutinib in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ibrutinib in CLL Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added 'B-cell chronic lymphocytic leukemia' to the study's Conditions section.
    Difference
    0.0%
    Check dated 2026-04-02T15:43:23.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Page revision updated to v3.5.0, replacing the previous v3.4.3 revision.
    Difference
    0.0%
    Check dated 2026-03-19T06:40:58.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:21:02.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Study status updated to Completed; results have been posted and enrollment and completion dates updated.
    Difference
    0.0%
    Check dated 2026-03-04T23:42:54.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The change is a minor version update (v3.4.2 replacing v3.4.1) and does not affect study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-11T11:32:20.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    A new page revision, v3.4.1, was added and the previous revision v3.4.0 was removed; this appears to be a backend/UI version update rather than a change to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T07:41:05.000Z thumbnail image

Stay in the know with updates to Nivolumab Ibrutinib in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ibrutinib in CLL Clinical Trial page.